INHD · Inno Holdings Inc.

Current Thesis

Inno Holdings' remaining recovery hypothesis is that its reported cash supports a return to the September 4 market close of $4.53 before a weekly close below $3.05 ends that hypothesis. This is a narrower, low-conviction price-recovery case; the earlier balance-sheet thesis already failed its published $4.00 weekly condition, with the September 18, 2026 close at $3.05. That failure remains part of the record.

The narrative is dead — the September 18 close extended the failure documented in the September 6 note, while the supplied adjusted price series records a three-month decline of 92.3%. The remaining fundamental evidence is historical: the June 30, 2026 accounts reported $33,238,616 of cash and a nine-month net loss of $2,720,214. Those figures establish reported liquidity and continuing losses; they do not establish September cash or an executable liquidation value. Quarterly report filed August 18, 2026.

The fresh disclosure located since the previous note concerns compensation. Apex Wire classifies Chief Executive Officer Wei Ding's September 11, 2026 Form 4 as an award of 30,000 shares. That classification supplies no evidence of discretionary insider demand, and the sample is too small to support a broader positioning claim. Apex Wire filing summary.

Bullish and bearish views on Inno Holdings Inc.

The model's bull view on Inno Holdings Inc. (INHD), in brief: Reported cash supports further scrutiny. The bear view: The published threshold has failed. The September 18, 2026 market close of $3.05 was below the $4.00 weekly invalidation published in the September 6 dossier. The supplied series also places the shares 99.8% below their adjusted 52-week high; neither observation demonstrates a… Both cases follow in full.

Bull Case

• Reported cash supports further scrutiny. The June 30, 2026 quarterly accounts reported cash of $33,238,616 and stockholders' equity of $55,634,839. A balance-sheet recovery interpretation depends on subsequent audited accounts reconciling those assets and the outstanding share count; an adverse restatement would break that interpretation. August 18 quarterly report.
• Operating results improved historically. Revenue for the nine months ended June 30, 2026 was $4,456,054 against $1,760,350 a year earlier, while net loss narrowed to $2,720,214 from $5,505,169. These are measured historical improvements, with no supplied forecast establishing their continuation. August 18 quarterly report.

Bear Case

• The published threshold has failed. The September 18, 2026 market close of $3.05 was below the $4.00 weekly invalidation published in the September 6 dossier. The supplied series also places the shares 99.8% below their adjusted 52-week high; neither observation demonstrates a reversal.
• Financing complicates the asset claim. The August 18, 2026 quarterly disclosure reported $5,435,576 of proceeds collected in July under a $60 million at-the-market equity program. That documents financing activity, but supplies no September issuance total or current share count. Quarterly report.
• Finance leadership changed before year-end. The August 31, 2026 Form 8-K disclosed Mengshu Shao's departure as director and chief financial officer effective August 25, with Mei Wang appointed interim chief financial officer. The filing states that the resignation did not result from disagreements; the timing alone does not establish an accounting problem. SEC filing record.

Setup & Price Structure

The supplied split-adjusted series records market closes of $5.61 on August 28, $4.53 on September 4 and $3.05 on September 18, 2026. These observations establish lower dated closes. They do not provide the intervening daily range or volume needed to identify a defended support shelf.

The September 18 reference close of $3.05 defines the new recovery test's lower boundary; it is not claimed as established support. A weekly close at or above $4.53 would complete that narrowly defined recovery before invalidation. The previous $4.00 condition remains a failed historical threshold, rather than evidence that the former thesis survived.

The supplied 14-period relative strength index (RSI) was 4.0 on September 18, 2026. That measures recent price momentum and supplies no independent timing evidence for a rebound. No dated moving-average value, short-interest series or retail-participation measure accompanies the September 18 observations, so the evidence does not support a quantified crowding assessment or a current short-squeeze claim.

The September 11 award disclosure also changes how subsequent share-count growth should be interpreted. Apex Wire identifies compensation shares, so a higher future company share count would require reconciliation among compensation and financing sources; an increase alone would not prove additional at-the-market issuance. Apex Wire filing summary.

Catalyst Calendar (next 30 days)

• September 30, 2026 — fiscal year-end. The company's SEC filing record identifies a September fiscal year-end. This is the accounting measurement date, not a confirmed earnings announcement or cash-verification event. SEC company filing record.

As of September 20, 2026, no confirmed company announcement date within the next 30 days was located. The fiscal year-end therefore does not supply a dated information catalyst for the recovery hypothesis. A fiscal 2026 annual-report publication date remains unconfirmed.

What Would Change Our Mind

Failure to retain the September 18 reference close would end the newly defined recovery case: a weekly close below $3.05 invalidates it before a weekly close at or above $4.53 completes it. This is a prospective test separate from the already breached $4.00 condition published on September 6.

A completed price recovery would settle only that narrow market test. Reinstating an asset-value thesis would additionally require audited disclosure reconciling the June 30, 2026 reported cash of $33,238,616, subsequent financing and compensation issuance. An adverse restatement of that cash figure would defeat the balance-sheet rationale even if the price recovered.

Correlation Notes

This remains a single-name situation. The dated evidence concerns company financing disclosed August 18, finance leadership disclosed August 31 and an executive award filed September 11, 2026; none establishes an oil-price or broad artificial-intelligence equity relationship.

No matched benchmark-return series accompanies the September 18 price observations. The evidence therefore supports neither a numerical correlation estimate nor a claim that a sector advance would repair the failed company-specific structure.